Hands on workshops. 08:00-10:15 Session 1 - LAA morphology and imaging Moderator: Saibal Kar, MD / Shakeel A. Qureshi, MD / Bushra Rana, MD
|
|
- Silvia Gallagher
- 5 years ago
- Views:
Transcription
1 Friday, November 20th, :00-18:30 Registration 07:00-08:00 Welcome coffee Hands on workshops 08:00-10:15 Session 1 - LAA morphology and imaging Moderator: Saibal Kar, MD / Shakeel A. Qureshi, MD / Bushra Rana, MD TEE before and during LAA closure: case based lecture Bushra Rana, MD 3D TEE sizing of the ostium and matching device size by area Martin W. Bergmann, MD LAAC imaging implantation of a Watchman with a micro-tee Martin Swaans, MD Intraprocedural angiography without echo Fabian Nietlispach, MD Rotational angiography: one step forward Tom De Potter, MD TEE Follow-up: thrombus and residual leak Bushra Rana, MD ICE guidance during LAA closure Jens Erik Nielsen-Kudsk, MD CT before and after LAA closure Sergio Berti, MD CT image analysis using Osirix Apostolos Tzikas, MD CT image analysis using 3mensio Mark Spence, MD Echonavigator Sameer Gafoor, MD 10:15-10:45 Coffee & tea break 10:45-11:45 Session 2 - LAA closure with the LAmbre occluder Moderator: Jai-Wun Park, MD / Yat-Yin Lam, MD Device design and anatomical inclusion/exclusion criteria and LAmbre EU clinical trial results
2 Jai-Wun Park, MD LAmbre step by step and advances tips and tricks Yat-Yin Lam, MD Case presentations and LAmbre China clinical trial results He Huang, MD 11:45-13:00 Session 3 - LAA closure with the Watchman Occluder Moderator: Saibal Kar, MD / David Foley, MD / Matthew Price, MD Device design and anatomical inclusion/exclusion criteria Saibal Kar, MD Watchman step by step and advances tips and tricks Martin W. Bergmann, MD Case examples Peter Sick, MD Case examples with Watchman Flx Horst Sievert, MD 13:00-14:00 Lunch session - Abstracts Moderator: Stefan Bertog, MD / Simon Lam, MD / Sameer Gafoor, MD Rationale of cerebral protection devices in left atrial appendage occlusion Felix Meincke, MD Cross-sectional computed tomographic superior to 2D and 3D TEE for LAA characterization of size and therefore device selection Dee Dee Wang, MD Deliverability, conformability and healing response of Watchman FLX LAAC device Elena Ladich, MD A comparison of 2-D and 3-D echocardiography imaging during percutaneous left atrial appendage closure (LAAO) Katarzyna Mitrega, MD A comparison of procedural and short-term clinical outcomes of left atrial appendage occlusion between Amplatzer cardiac plug and Watchman device in patients with non-valvular atrial fibrillation: from korean multicenter registry Seung Hun Lee, MD 14:00-15:00 Session 4 - LAA occlusion with the new Amulet Moderator: Kevin P. Walsh, MD / Fabian Nietlispach, MD Device design and anatomical inclusion/exclusion criteria Apostolos Tzikas, MD
3 Amulet: step by step and advance tips and tricks Thorsten Lewalter, MD Interactive case examples; what do you think? KR Julian Chun, MD Case example challenging anatomy- Chicken wing Kevin P. Walsh, MD implanting Amulet using CT + ICE imaging Jens Erik Nielsen-Kudsk, MD 15:00-16:00 Session 5 - Transpericardial LAA closure with the LARIAT device Moderator: Neil Wilson, MD / / Stefan Bertog, MD Patient selection for the LARIAT procedure Abdi Rasekh, MD LARIAT step by step and recent device and technique modifications What happens to the LAA after epicardial ligation? Krzysztof Bartus, MD Post procedural management after LARIAT Abdi Rasekh, MD 16:00-16:30 Coffee & tea break 16:30-17:30 Session 6 - LAA closure with the WaveCrest Occluder Moderator: Neil Wilson, MD / Sameer Gafoor, MD Introduction of new design features of the Coherex WaveCrest LAA occlusion system Marcus Sandri, MD Recorded case KR Julian Chun, MD A challenging case with Coherex WaveCrest Martin W. Bergmann, MD Saturday, November 21st, :00-18:00 Registration 07:00-08:00 Welcome coffee
4 08:00-10:00 Session 7 - Why and when to close the LAA Moderator: Shakeel A. Qureshi, MD / Stefan Bertog, MD Embryology, anatomy and function of the LAA Piotr Suwalski, MD The rationale for LAA closure in 2015: bleeding risk, stroke risk new data Indication for LAA closure current status and future perspectives - US view Matthew Price, MD current status and future perspectives - EU view Peter Sick, MD current status and future perspectives - UK view Jan Kovac, MD Update on NOAC clinical trial data - do NOACs obviate the need for LAA Closure? Abdi Rasekh, MD My real-life experience with LAA closure how I convinced referrals and built a network Patrizio Mazzone, MD 10:00-10:30 Coffee & tea break 10:30-12:30 Session 8 - New clinical trial data A Moderator: Saibal Kar, MD / Neil Wilson, MD / Sameer Gafoor, MD Antithrombotic therapy after LAA closure: pathophysiology, clinical experience, trial results Stefan Bertog, MD The Watchman device - latest data from the randomized clinical trials Matthew Price, MD The Watchman device - latest data from real life registries Horst Sievert, MD 12:30-13:15 Lunch break
5 13:15-14:15 Session 9 - New clinical trial data B Moderator: Shakeel A. Qureshi, MD / Stefan Bertog, MD ACP and Amulet Simon Lam, MD LARIAT A comparison of leak rates with the LARIAT versus the Watchman 14:15-15:45 Session 10 - New LAA closure devices and techniques Moderator: Neil Wilson, MD / Stefan Bertog, MD / Sameer Gafoor, MD Amplatzer Amulet Kevin P. Walsh, MD Lifetech Yat-Yin Lam, MD Occlutech Jai-Wun Park, MD PROLIPSIS E.B. Sideris, MD Watchman FLX design and potential benefits of a new device Marcus Sandri, MD First clinical experience with the Watchman FLX device Saibal Kar, MD AtriClip (Atricure) Piotr Suwalski, MD Cardia Denis Haagen Acoredis Marcus Sandri, MD 15:45-16:00 Coffee & tea break 16:00-18:00 Session 11 - Challenging cases and complications Moderator: Shakeel A. Qureshi, MD / Neil Wilson, MD
6 Case 1: late follow-up Sameer Gafoor, MD Case 2: thrombus and Leak Simon Lam, MD Case : LAA closure dislodgment and bailout approach Evgeniy Merkulov, MD Closing remarks and thank you Horst Sievert, MD / Shakeel A. Qureshi, MD / Neil Wilson, MD
Scientific Program of LAA 2014
Scientific Program of LAA 2014 Friday, November 14th, 2014 08:00-18:30 Registration 08:00-08:05 Welcome 08:05-08:45 Session 1: How Morphology Affects Short- and Long-term Outcome? What you Need to Know
More informationScientific Program of CSI Focus Imaging 2017
Scientific Program of CSI Focus Imaging 2017 Wednesday, June 28th, 2017 07:00-08:00 Registration and breakfast in the exhibition area 08:00-08:05 Welcome and introduction Moderator: Horst Sievert, MD /
More informationWhich System Is better?: Watchman or Cardiac Plug or Something Else?
ANGIOPLASTY SUMMIT-TCTAP 2012 Seoul, Korea, April 24-27, 2012 Which System Is better?: Watchman or Cardiac Plug or Something Else? Horst Sievert, Annkathrin Brauth, Isabel Schulmeyer, Patrick Boehm, Jonas
More informationModern aspects in multidisciplinary thromboembolic prophylaxis. AMPLATZER Left Atrial Appendage data update
Modern aspects in multidisciplinary thromboembolic prophylaxis AMPLATZER Left Atrial Appendage data update Igal Moarof, MD Interventional Cardiology Kantonsspital Aarau Potential conflicts of interest
More informationPercutaneous Epicardial LAA Closure: When Does it Make Sense?
Percutaneous Epicardial LAA Closure: When Does it Make Sense? Petr Neuzil, MD,PhD, FESC Professor of Medicine Cardiology department Na Homolce Hospital, Prague, Czechia petr.neuzil@gmail.com Disclosures
More informationAtrial fibrillation (AF) remains the most common
The Spectrum of Devices for Percutaneous Left Atrial Appendage Occlusion A look at current and emerging nonpharmacologic stroke prevention therapies. BY LLUIS ASMARATS, MD, AND JOSEP RODÉS-CABAU, MD Atrial
More informationLAA Occluders: The Right Device for the Right Patient ACC/SHA MEETING OCTOBER 31 ST 2015 JEDDAH, KSA OMER A. M. ELAMIN, MD, FACC
LAA Occluders: The Right Device for the Right Patient ACC/SHA MEETING OCTOBER 31 ST 2015 JEDDAH, KSA OMER A. M. ELAMIN, MD, FACC INTERVENTIONAL CARDIOLOGIST DIRECTOR, ADULT CARDIOLOGY FELLOWSHIP TRAINING
More informationContinuing Cardiology Education
Continuing Cardiology Education REVIEW ARTICLE Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives A. Tzikas 1 & T.
More informationDavid Hildick-Smith, John Camm, Hans-Christoph Diener, Ulf Landmesser, Vincent Paul, Boris Schmidt, Magnus Settergren, Emmanuel Teiger, Claudio Tondo
THE AMULET STUDY: A Multicenter, Prospective Registry of the Amulet Left Atrial Appendage Closure Device for Stroke Prevention in Patients with Atrial Fibrillation David Hildick-Smith, John Camm, Hans-Christoph
More informationRole of cardiac imaging for catheterbased left atrial appendage closure
Role of cardiac imaging for catheterbased left atrial appendage closure Ana G. Almeida, MD, PhD Cardiology University Hospital Santa Maria, Lisbon Ana G. Almeida, MD, PhD, FESC University Hospital Santa
More informationSURGICAL VS ELECTROPHYSIOLOGICAL INTERVENTIONS FOR CARDIAC ARRHYTHMIAS DEBATE 2: LAA CLOSURE IS BEST DONE WITH DEVICES
SURGICAL VS ELECTROPHYSIOLOGICAL INTERVENTIONS FOR CARDIAC ARRHYTHMIAS DEBATE 2: LAA CLOSURE IS BEST DONE WITH DEVICES Dr. Marco Barbierato Interventional Cardiology Cardio-Thoraco-Vascular Department
More informationLeft Atrial Appendage Closure Devices. Atrial Fibrillation 10/11/2017
Left Atrial Appendage Closure Devices Emile Daoud, MD Chief, Cardiac Electrophysiology Wexner Medical Center, The Ohio State University Atrial Fibrillation 1 Adjusted Annual Stroke Risk Using CHA 2 DS
More informationDevices to Protect Against Stroke in Atrial Fibrillation
Devices to Protect Against Stroke in Atrial Fibrillation Jonathan C. Hsu, MD, MAS Associate Clinical Professor Division of Cardiology, Section of Cardiac Electrophysiology June 2, 2018 Disclosures Honoraria
More information3 rd BELGIAN LEFT ATRIAL APPENDAGE OCCLUSION MEETING. Friday Hotel Dolce La Hulpe Brussels
3 rd BELGIAN LEFT ATRIAL APPENDAGE OCCLUSION MEETING Friday 23.11.2018 Hotel Dolce La Hulpe Brussels MEETING OBJECTIVES Dear Colleagues, Oral anticoagulation remains the mainstay of therapy for stroke
More informationLeft Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke Saibal Kar, MD
Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke Saibal Kar, MD Director of Interventional Cardiac Research Cedars Sinai Medical Center Disclosure Statement
More informationDisclosures 6/16/2015. Preventing Stroke in Atrial Fibrillation Warfarin Intolerance / Non-Compliance
6/16/2015 Data Behind LAA Closure This is Ready for Prime Time! Vivek Y. Reddy, MD Helmsley Trust Professor of Medicine Director, Cardiac Arrhythmia Service The Mount Sinai Hospital vivek.reddy@mountsinai.org
More informationEurope. Other LAA occlusion devices are in clinical development.
EXPERT REVIEW INTERVENTIONS FOR STRUCTURAL HEART DISEASE Left atrial appendage closure for stroke prevention in nonvalvular atrial fibrillation: rationale, devices in clinical development and insights
More informationAbstract 1 INTRODUCTION ORIGINAL ARTICLE
Received: 5 October 2017 Revised: 2 November 2017 Accepted: 6 November 2017 DOI: 10.1111/jce.13385 ORIGINAL ARTICLE Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder
More informationLeft Atrial Appendage Occlusion in the Era of Novel Anticoagulants
Left Atrial Appendage Occlusion in the Era of Novel Anticoagulants Saibal Kar, MD, FACC, FSCAI Professor of Medicine Director of Interventional Cardiac Research Heart Institute, Cedars-Sinai Medical Center,
More informationLeft atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
Received: 15 May 2017 Revised: 21 June 2017 Accepted: 26 June 2017 DOI: 10.1002/clc.22764 REVIEWS Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation Rizma Jalees
More informationUpdate in Left Atrial Appendage Closure Devices. Faisal Al-Samadi MBBS, FRCPC, FACP, FACC, FSCAI, FHRS
Update in Left Atrial Appendage Closure Devices Faisal Al-Samadi MBBS, FRCPC, FACP, FACC, FSCAI, FHRS Atrial Fibrillation - Overview Higher stroke risk for older patients and those with prior stroke or
More informationRole of Imaging in Complex LAA Closure Anatomies
Role of Imaging in Complex LAA Closure Anatomies Sameer Gafoor 1,2 1 Swedish Heart and Vascular: Ming Zhang, Paul Huang, Darryl Wells, Adam Zivin, John Petersen II, Madalena Petrescu, Nimish Muni, Eric
More informationLeft Atrial Appendage Closure for Atrial Fibrillation 2015 UPDATE
Left Atrial Appendage Closure for Atrial Fibrillation 2015 UPDATE Adam Greenbaum, MD NCVH Detroit 2015-09-12 Disclosures Former proctor: SentreHEART Discussion may include the use of non-fda approved devices
More informationNHS England. Anticoagulation Therapy
NHS England Evidence review: Clinical and Cost- Effectiveness and Adverse Events Associated with Left Atrial Appendage Occlusion in Patients for Whom Anticoagulation Therapy is Contraindicated Anticoagulation
More informationLeft atrial appendage closure: outcomes and challenges
Neth Heart J (2017) 25:143 151 DOI 10.1007/s12471-016-0929-0 REVIEW ARTICLE Left atrial appendage closure: outcomes and challenges H. S. Suradi 1,2,3 Z.M.Hijazi 4 Published online: 9 December 2016 The
More informationClinical Data Summary & Discussion Of the Ultraseal Left Atrial Appendage (LAA) Closure Device
Clinical Data Summary & Discussion Of the Ultraseal Left Atrial Appendage (LAA) Closure Device The clinical data used to support the CE marking of the Ultraseal LAA Closure device comes from three sources.
More informationFive years of keeping a watch on the left atrial appendage how has the WATCHMAN fared?
Perspective Five years of keeping a watch on the left atrial appendage how has the WATCHMAN fared? Mohammad-Ali Jazayeri, Venkat Vuddanda, Valay Parikh, Madhav Lavu, Donita Atkins, Y. Madhu Reddy, Jayant
More informationLeft-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Medical Policy Manual Surgery, Policy No. 195 Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Next Review: November 2019 Last Review: January 2019 Effective: February
More informationLeft Atrial Appendage Closure in SCRIPPS CLINIC
Left Atrial Appendage Closure in Atrial Fibrillation to Prevent Stroke Matthew J. Price MD Director, Cardiac Catheterization Laboratory Scripps Clinic La Jolla, CA, USA price.matthew@scrippshealth.org
More informationLeft Atrial Appendage Closure: Moving Beyond Blood Thinners to Prevent Stroke in Atrial Fibrillation October 29, 2016
Left Atrial Appendage Closure: Moving Beyond Blood Thinners to Prevent Stroke in Atrial Fibrillation October 29, 2016 Jesse Jorgensen, MD, FACC Director, Cardiac Cath Lab, Greenville Health System Disclosures
More informationLeft Atrial Appendage Closure: The Good, The Bad and The Ugly
Left Atrial Appendage Closure: The Good, The Bad and The Ugly John D. Hummel, MD Director of Electrophysiology Research Ross Heart Hospital, The Ohio State University Columbus, Ohio USA Disclosures Modest
More informationEndocardial LAA Occlusion: Which Device for Which Patient?
Endocardial LAA Occlusion: Which Device for Which Patient? Roy Beinart, MD Davidai Arrhythmia Center The Leviev Heart Center Sheba Medical Center Sheba Medical Center Tel Hashomer The Leviev Heart Center
More informationIntroduction EP WIRE. ... Keywords
Europace (217), 1 6 doi:1.3/europace/eux254 EP WIRE Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association
More informationCase Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device
273 Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device Amena Hussain MD, Muhamed Saric MD, Scott Bernstein MD, Douglas Holmes MD, Larry Chinitz MD NYU Langone Medical Center, United
More informationDevices for Stroke Prevention. Douglas Ebersole, MD Interventional Cardiology Watson Clinic LLP
Devices for Stroke Prevention Douglas Ebersole, MD Interventional Cardiology Watson Clinic LLP Overview Left Atrial Appendage Closure FDA Approved Watchman Investigational Amulet PFO Closure Atrial Fibrillation
More informationUpdate in Left Atrial Appendage Occlusion: More Options
Update in Left Atrial Appendage Occlusion: More Options Sajjad A Sabir, MD Director, Structural Heart Disease Program Director, Interventional Echocardiography Director, Heart Valve Clinic Non-Valvular
More informationMedical Policy Manual. Topic: Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation. Date of Origin: December 2011
Medical Policy Manual Topic: Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Date of Origin: December 2011 Section: Medicine Last Reviewed Date: October 2013 Policy No:
More informationCryptogenic Stroke: A logical approach to a common clinical problem
Cryptogenic Stroke: A logical approach to a common clinical problem Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Speakers Bureau Boston Scientific
More informationLeft atrial appendage occlusion
Kardiologie Left atrial appendage occlusion Mischa Kühne Kardiolunch, 10.9.2015 Overall stroke rate 5% per year CHA 2 DS 2 VASC score Most AF patients need protection from stroke ESC guidelines AF, 2010/2012
More informationLeft atrial appendage closure with the Amplatzer Cardiac Plug: Rationale for a higher degree of device oversizing at implantation
ORIGINAL ARTICLE Cardiology Journal 2015, Vol. 22, No. 2, 201 205 DOI: 10.5603/CJ.a2014.0063 Copyright 2015 Via Medica ISSN 1897 5593 Left atrial appendage closure with the Amplatzer Cardiac Plug: Rationale
More informationPercutaneous Left Atrial Appendage Closure - Ready for prime time?
Percutaneous Left Atrial Appendage Closure - Ready for prime time? Simone Musco, MD, FACC, FHRS The International Heart Institute of Montana ACP Montana chapter meeting September 28th 2017 Simone.Musco@providence.org
More informationAppendage Closure. Jason Rogers, MD. Director, Interventional Cardiology UC Davis Medical Center Sacramento, California
Appendage Closure Jason Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Sacramento, California Left Atrium: Atrial Fibrillation Left Atrial Appendage Left Atrium Incidence of Atrial
More informationPatients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine
Patients selection criteria for LAA occlusion Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Atrial Fibrillation The most common cardiac arrhythmia. Confers
More informationAtrial fibrillation (AF), one of the
Hellenic J Cardiol 2013; 54: 408-412 Case Report Left Atrial Appendage Occlusion with the Amplatzer Amulet for Stroke Prevention in Atrial Fibrillation: The First Case in Greece Apostolos Tzikas, Lambros
More informationLeft atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives
Review Article Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives Bin Kong 1,2, Yu Liu 1,2, He Huang 1,2, Hong Jiang 1,2, Congxin
More informationCommercial Products Percutaneous left atrial appendage closure is considered medically necessary when the criteria above is met.
Medical Coverage Policy Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation EFFECTIVE DATE: 07 01 2016 POLICY LAST UPDATED: 09 04 2018 OVERVIEW Stroke prevention
More informationICE 2012 Ioannina,
ICE 2012 Ioannina, 15-12-2012 Case presentation Left Atrial Appendage Occlusion therapy for Stroke Prevention in Atrial Fibrillation Apostolos Tzikas MD, PhD, FESC Interventional Cardiology Congenital
More information16th ANGIOPLASTY SUMMIT-TCTAP TCTAP 2011 Seoul, Korea, April 27 29, 2011 Left Atrial Appendage Closure State of the Art Horst Sievert, Nina Wunderlich, Maik Gonzaga, Annkathrin Braut, Ilona Hofmann CardioVascular
More informationTechnique, Risk, and Benefit. T. Santoso University of Indonesia Medical School,
Left Atrial Appendage Closure Technique, Risk, and Benefit T. Santoso University of Indonesia Medical School, Medistra Hospital, Jakarta, Indonesia Percutaneous LAA Closure Devices PLAATO (no longerdeveloped)
More informationLAmbre LAA Occluder Updates
LAmbre LAA Occluder Updates 4 th Asia Pacific Congenital & Structural Interventional Symposium 6 th June, 2013 Hong Kong Yat-yin LAM MBBS MRCP FHKCP FHKAM FESC FRCP FACC MD Associate Professor, Prince
More informationMEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES DESCRIPTION. Page: 1 of 9
Page: 1 of 9 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICES Policy Number 7.01.92 Category Technology assessment Effective Date 08/20/15 Revised
More informationLeft Atrial Appendage Closure: Techniques and Guidelines. Mohammad Shenasa, MD Heart & Rhythm Medical Group San Jose, CA
Left Atrial Appendage Closure: Techniques and Guidelines Mohammad Shenasa, MD Heart & Rhythm Medical Group San Jose, CA May is Stroke Awareness Month 2 September is AF Awareness Month Lecture Highlights
More informationLeft Atrial Appendage Closure Techniques: 2015
Left Atrial Appendage Closure Techniques: 2015 Ramon Quesada, MD, FACP, FACC, FSCAI Medical Director, Interventional Cardiology & Cardiac Research Medical Director, Structural Heart and TAVR Program Baptist
More informationClinical Policy Bulletin: Cardiac Devices and Procedures for Occlusion of the Left Atrial Appendage
Close Window Enter CPB Search Term: Go Clinical Policy Bulletin: Cardiac Devices and Procedures for Occlusion of the Left Atrial Appendage Number: 0791 Policy *Please see amendment for Pennsylvania Medicaid
More informationThessaloniki October 9, Apostolos Tzikas MD, PhD, FESC
7 th IICE Congress Thessaloniki October 9, 2014 Left atrial appendage occlusion with the Amplatzer Amulet: a case report Apostolos Tzikas MD, PhD, FESC Interventional Cardiologist Structural & Congenital
More informationTrick or Treat 2: A New Era of Stroke Prevention in AF? WATCHMAN and LARIAT?
Trick or Treat 2: A New Era of Stroke Prevention in AF? WATCHMAN and LARIAT? Disclosure SentreHeart, Inc Consultant Equity holder A cardiac disease that kills by producing emboli The most severe consequence
More informationWilliam A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA
William A. Gray MD System Chief of Cardiovascular Services, President, Wynnewood, Pennsylvania USA What does Guilty until Effective mean? A fact is a simple statement that everyone believes. It is innocent
More informationAMPLATZER Amulet Left Atrial Appendage Occluder
AMPLATZER Amulet Left Atrial Appendage Occluder EXPECT THE BEST OF ALL WORLDS FROM YOUR LEFT ATRIAL APPENDAGE OCCLUDER: Ease of use, the broadest range of sizes and a design allowing for a complete ostial
More informationPERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION:
PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION: Procedural Experience and Clinical Follow-up with the AMPLATZER Cardiac Plug and AMPLATZER Amulet
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute ischemic stroke TOAST classification of, 270 Acute myocardial infarction (AMI) cardioembolic stroke following, 207 208 noncardioembolic
More informationOcclusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France
Occlusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France LAA Occlusion Is there a real future? Background Protect AF Trial Other Studies CAP, ASAP, Prevail Left Atrial Appendage
More informationTHINK OUTSIDE THE PILLBOX
WATCHMAN : A CLINICALLY PROVEN AND SAFE THERAPY FOR YOUR NVAF PATIENTS WATCHMAN reduces the risk of stroke in NVAF patients as effectively as warfarin WATCHMAN also reduces the long-term risk of bleeding
More informationPathology of Atrial Septal Defects. To Close or not to Close?: Atrial Septal Defects are NOT That Simple-Sometimes
Scientific Program Thursday, June 7, 2007 09:00 19:00 Registration 09:00 10:00 Breakfast at the Congress Center 10:00 10:05 Opening Remarks H. Sievert 10:05 10:15 Follow-up of the Patients 2006 C. Heinisch
More informationNCVH Birmingham 2013 August 24, Michael S. Bailey, MD Birmingham Heart Clinic
NCVH Birmingham 2013 August 24, 2013 Michael S. Bailey, MD Birmingham Heart Clinic NCVH Birmingham 2015 August 29, 2015 Michael S. Bailey, MD Birmingham Heart Clinic Left Atrial Anatomy Part of a larger
More informationMEDICAL POLICY SUBJECT: PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICES EFFECTIVE DATE: 08/20/15 REVISED DATE: 10/20/16, 11/16/17
MEDICAL POLICY SUBJECT: PERCUTANEOUS LEFT ATRIAL CATEGORY: Technology assessment PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply.
More informationLAA 2015 Abstracts How to Close the Left Atrial Appendage
Meeting Abstracts Journal of Structural Heart Disease, December 2015, Volume 1, Issue 4: 155-160 DOI: http://dx.doi.org/10.12945/j.jshd.2015.901-15 Published online: December 2015 LAA 2015 Abstracts How
More informationLeft Atrial Appendage Occlusion: Shutting Out Embolic Disease Without Anticoagulation
Left Atrial Appendage Occlusion: Shutting Out Embolic Disease Without Anticoagulation Zoltan G. Turi, M.D. Rutgers Robert Wood Johnson Medical School New Brunswick, NJ Disclosure Information Zoltan G.
More informationATRIAL SEPTAL CLOSURE AND LEFT ATRIAL APPENDAGE OCCLUSION: INDICATIONS AND GUIDANCE ECHOCARDIOGRAPHY IN INTERVENTIONAL CARDIOLOGY
ATRIAL SEPTAL CLOSURE AND LEFT ATRIAL APPENDAGE OCCLUSION: INDICATIONS AND GUIDANCE Aristides G. Panlilio, MD, FPCP, FPCC,FPSE, FASE Philippine Heart Center Chinese General Hospital and Medical Center
More informationSafety and efficacy results in the EWOLUTION all-comers LAA closure study: DAPT subgroup
Safety and efficacy results in the EWOLUTION all-comers LAA closure study: DAPT subgroup Martin W. Bergmann, Hüseyin Ince, Stephan Kische, Thomas Schmitz, Felix Meincke, Boris Schmidt, David Foley, Timothy
More informationGauging stroke risk across the AF spectrum and selecting the appropriate patient for LAA closure. Miguel Valderrábano, MD
Gauging stroke risk across the AF spectrum and selecting the appropriate patient for LAA closure Miguel Valderrábano, MD Risk of Stroke in Atrial Fibrillation CHADS 2 -CHA 2 DS 2 -VASc Scores Adjusted
More informationLeft Atrial Appendage Occlusion
Left Atrial Appendage Occlusion A new strategy to prevent stroke in atrial fibrillation Ashok Talreja MD and Arijit Chanda MD VHVI symposium 24th February 2018 Outline of presentation 1. Risk of stroke
More information[N] = No product variation, policy applies as stated [Y] = Standard product coverage varies from application of this policy, see below
Original Issue Date (Created): July 26, 2011 Most Recent Review Date (Revised): November 26, 2013 Effective Date: February 1, 2014 I. POLICY The use of percutaneous left-atrial appendage closure devices
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Percutaneous Left Atrial Appendage Closure Device Page 1 of 22 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Percutaneous Left Atrial Appendage Closure Devices
More informationJoint Congress PAFCIC Complex PCI meeting
Joint Congress PAFCIC Complex PCI meeting October 18-20, 2018, Nairobi, KENYA The Program : - Interactive sessions - Practical workshops - Key note lectures - Live transmissions - Poster and oral presentations
More informationRevised by Piero Maglia, Gennaro Santoro. Consensus Document Approval Faculty in appendix
European Heart Journal Supplements (2017) 19 (Supplement D), D333 D353 The Heart of the Matter doi:10.1093/eurheartj/sux008 ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of
More informationRecent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease
Received: November 22, 2016 Accepted: March 7, 2017 Published online: April 27, 2017 Review Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease Federico
More informationPercutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Policy Number: 2.02.26 Last Review: 6/2014 Origination: 1/2012 Next Review: 12/2014 Policy Blue Cross and
More informationCase Report Pulmonary Vein Compression After Implantation of a Left Atrial Appendage Occluder: Presentation and Discussion of a Case
194 Case Report Pulmonary Vein Compression After Implantation of a Left Atrial Appendage Occluder: Presentation and Discussion of a Case Maryam Ayati MD, Feifan Ouyang MD, KH Kuck MD Department of cardiology,
More informationFilling the gap: interventional occlusion of incompletely ligated left atrial appendages
Europace (2015) 17, 64 68 doi:10.1093/europace/euu164 CLINICAL RESEARCH Ablation for atrial fibrillation Filling the gap: interventional occlusion of incompletely ligated left atrial appendages Stefano
More informationEHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Europace (2014) 16, 1397 1416 doi:10.1093/europace/euu174 EHRA/EAPCI CONSENSUS STATEMENT EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion Bernhard Meier (EAPCI Chairperson)
More informationPercutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Last Review Status/Date: December 2015 Page: 1 of 17 Devices for Stroke Prevention in Atrial Description Stroke prevention in atrial fibrillation is an important consideration. Treatment with anticoagulant
More informationWatchman. Left Atrial Appendage Closure Device. Uniquely engineered for the LAA 1-3 with proven safety and longterm efficacy. 4-8
TM Watchman Left Atrial Appendage Closure Device PROOF OFLEADERSHIP Uniquely engineered for the LAA 1-3 with proven safety and longterm efficacy. 4-8 Patients with AF have a 5x increased risk of stroke.
More informationCore Curriculum for the Cardiovascular Clinician
September 14 17, 2016 Heart House Washington, DC AGENDA Wednesday, September 14 PHARMACOLOGY WORKSHOP 5:30 p.m. Registration and Light Refreshments 6:00 p.m. Welcome and Introductions 6:15 p.m. CVD Guideline-driven
More informationDepartment of Neurology, Medical University of Silesia, Hospital No. 7, Professor Leszek Giec Upper Silesian Medical Centre, Katowice, Poland
Original paper Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy Anetta Lasek-Bal
More informationLeft Atrial Appendage Closure: The Rationale
Left Atrial Appendage Closure: The Rationale JOHN D. HUMMEL, MD DIRECTOR OF CLINCAL ELECTROPHYSIOLOGY RESEARCH PROFESSOR OF CLINICAL INTERNAL MEDICINE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER 1 Disclosures
More informationIncomplete surgical ligation of the left atrial appendage time for a new look at an old problem
Editorial Page 1 of 5 Incomplete surgical ligation of the left atrial appendage time for a new look at an old problem Arash Aryana, Rohit Bhaskar Mercy General Hospital and Dignity Health Heart and Vascular
More informationPercutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Section Medicine
2.02.26 Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Section Medicine Effective Date August 29, 2014 Subsection Cardiology Original Policy Date July 6,
More information9th Asia Pacific Congenital and Structural Heart Intervention Symposium
9th Asia Pacific Congenital and Structural Heart Intervention Symposium 6 7 October, 2018 Hong Kong Convention & Exhibition Centre, Hong Kong FINAL ANNOUNCEMENT & PRELIMINARY PROGRAM Pre-Conference Live
More informationPercutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Policy Number: 2.02.26 Last Review: 12/2018 Origination: 1/2012 Next Review: 12/2019 Policy Blue Cross and
More informationTogether. INFINITE POSSIBILITIES.
ST. JUDE MEDICAL IS NOW ABBOTT Together. INFINITE POSSIBILITIES. Abbott and St. Jude Medical have joined together. Visit us at EuroPCR 2017. Join us at our exciting scientific sessions, and explore our
More informationThe evolving role of left atrial appendage occlusion
ORIGINAL ARTICLE 288 A high-volume single-centre experience The evolving role of left atrial appendage occlusion Raffael A. Ghenzi, Slayman Obeid, Francesco Maisano, Maurizio Taramasso, Ronald Binder,
More informationPercutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Section: Medicine Effective Date: October 15, 2016 Last Review Status/Date: September 2016 Page: 1 of 16 Devices for Stroke Prevention in Atrial Description Stroke prevention in atrial fibrillation is
More informationLeft Atrial Appendage Closure
Left Atrial Appendage Closure Matthew J. Price MD Director, Cardiac Catheterization Laboratory Scripps Clinic La Jolla, CA, USA price.matthew@scrippshealth.org Risk Factors for Stroke From The Perspective
More informationEmerging Technologies in the Cath & EP Labs. EP Labs
Ohio-ACC 27 th Annual Meeting Emerging Technologies in the Cath & EP Labs EP Labs Mauricio Arruda, MD John R. Antonucci Master Clinician of Cardiovascular Innovation Director of Electrophysiology Center
More informationCSI Asia-Pacific March 5-7, 2015 Ho Chi Minh City, Vietnam Programme as of Jan 15, 2015
Thursday, March 5, 2015 7:00-19:00 Registration 7:55-8:00 Welcome and Introduction Course Directors 8:00-9:30 Session 1 Atrial Septal Defects Moderators: Worakan Promphan, Pham Gia Khai, Shakeel Qureshi
More informationReference: NHS England 1692
Clinical Commissioning Policy Proposition: Left Atrial Appendage Occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (Adults) Reference: NHS England
More informationAvoiding and Managing Complications During CAS: Lessons Learned
LINC 2019 Leipzig, Germany, Jan 22-25, 2019 Avoiding and Managing Complications During CAS: Lessons Learned Horst Sievert, Ilona Hofmann, Kolja Sievert, Laura Vaskelyte, Sameer Gafoor, Stefan Bertog, Predrag
More informationLeft atrial appendage (LAA) closure is now a commercially
Assessing Anatomy for Left Atrial Appendage Closure The roles of TEE and CTA in anatomic assessment and device selection for LAA closure. BY DEE DEE WANG, MD, AND MARVIN H. ENG, MD Left atrial appendage
More information8 th International Workshop on Interventional Pediatric Cardiology Milan, March 31 st - April 2 nd 2011
8 th International Workshop on Interventional Pediatric Cardiology Milan, March 31 st - April 2 nd 2011 MARCH 31 st 2011 7.15-7.50 REGISTRATION 7.50-8.00 WELCOME AND INTRODUCTION M. Carminati (Italy) 8.00-10.00
More information